Identification of multiple rate-limiting steps during the human mitochondrial transcription cycle in vitro by Lodeiro, M.F. et al.
Identification of Multiple Rate-limiting Steps during the
Human Mitochondrial Transcription Cycle in Vitro*□S
Received for publication, December 7, 2009, and in revised form, March 18, 2010 Published, JBC Papers in Press, March 29, 2010, DOI 10.1074/jbc.M109.092676
Maria F. Lodeiro, Akira U. Uchida, Jamie J. Arnold, Shelley L. Reynolds, Ibrahim M. Moustafa, and Craig E. Cameron1
From the Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, Pennsylvania 16802
Wehave reconstituted humanmitochondrial transcription in
vitro on DNA oligonucleotide templates representing the light
strand and heavy strand-1 promoters using protein components
(RNA polymerase and transcription factors A and B2) isolated
from Escherichia coli. We show that 1 eq of each transcription
factor and polymerase relative to the promoter is required to
assemble a functional initiation complex. The light strand pro-
moter is at least 2-fold more efficient than the heavy strand-1
promoter, but this difference cannot be explained solely by the
differences in the interaction of the transcription machinery
with the different promoters. In both cases, the rate-limiting
step for production of the first phosphodiester bond is open
complex formation. Open complex formation requires both
transcription factors; however, steps immediately thereafter
only require transcription factor B2. The concentration of
nucleotide required for production of the first dinucleotide
product is substantially higher than that required for subse-
quent cycles of nucleotide addition. In vitro, promoter-specific
differences in post-initiation control of transcription exist, as
well as a second rate-limiting step that controls conversion of
the transcription initiation complex into a transcription elonga-
tion complex. Rate-limiting steps of the biochemical pathways
are often those that are targeted for regulation. Like the more
complex multisubunit transcription systems, multiple steps
may exist for control of transcription in human mitochondria.
The tools and mechanistic framework presented here will facil-
itate not only the discovery of mechanisms regulating human
mitochondrial transcription but also interrogation of the struc-
ture, function, and mechanism of the complexes that are regu-
lated during human mitochondrial transcription.
Expression and maintenance of the mitochondrial genome
(mtDNA) are essential for mitochondria to produce energy,
function in other aspects of intermediary metabolism, contrib-
ute to pathogen sensing, and integrate into signal-transduction
pathways, especially those regulated by circadian rhythm and
nutritional status (1, 2). Mitochondrial dysfunction caused by
defects in mtDNA replication and translation attributable to
mutations in mitochondrial and nuclear genes contributes to
numerous diseases, including muscular dystrophies, cardiac dis-
eases, neurodegenerative disorders, diabetes, and certain cancers
(3–8).A linkbetween the cis- and trans-acting factors required for
mitochondrial transcription and disease has yet to be established,
likely because of limited information on the mechanism and reg-
ulation of mitochondrial transcription (1, 4, 9–11).
Human mtDNA is a 16,569-bp, double-stranded, circular
DNAthat encodes 13proteins essential for oxidative phosphor-
ylation, as well as the 2 ribosomal RNAs and 22 transfer RNAs
needed for production of these proteins in mitochondria (11,
12). The control (or D-loop) region of mtDNA contains cis-
acting sequences required for genome replication and tran-
scription. Three promoters exist in the control region as fol-
lows: the light strand promoter (LSP)2 and heavy strand
promoters (HSP) 1 and 2 (11, 12). These promoters give rise to
polycistronic RNAs that are further processed for proper gene
expression (11). HSP1 is located upstream of HSP2 and directs
the synthesis of the two ribosomal RNAs. Transcription from
HSP1 is terminated at the end of the 16 S rRNA gene by the
action of a terminator whose function requires binding by the
mitochondrial termination factor (13). Premature termination
of transcription initiated from LSP is caused by a conserved,
GC-rich sequence referred to as conserved sequence box II
(CSBII), and this product may be the primer for replication of
the leading strand of mtDNA (14).
The human mitochondrial transcription machinery con-
sists of the mitochondrial RNA polymerase (h-mtRNAP or
POLRMT), which is related to the single-subunit RNA polym-
erase of bacteriophage T7, mitochondrial transcription factor
A (h-mtTFA also known as TFAM), and mitochondrial tran-
scription factor B1 or B2 (h-mtTFB1, h-mtTFB2). The
h-mtRNAP is a 130-kDa protein with a carboxyl-terminal core
polymerase domain that exhibits homology to T7RNAP and an
amino-terminal domain that is unique to T7-RNAP-like enzymes
that require transcription factors for function (11). The amino-
terminal domain contains pentatricopeptide repeats, which are
known to bindRNA, that have beenproposed to couple transcrip-
tion to translation (4, 11, 15). The h-mtTFA is a member of the
highmobility group familyofproteins (16),which bind, bend, and
wrap DNA (17). Binding of h-mtTFA to promoters LSP and
HSP1 upstream of the transcription start site (TSS) has been
demonstrated by DNase I footprinting (18). In addition to tran-
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scription initiation, h-mtTFA serves a role in DNA packaging
andmaintenance ofmtDNA (19, 20). h-mtTFB1 andh-mtTFB2
are two homologous proteins, with sequence homology to ribo-
somal RNA dimethyltransferases (21, 22). h-mtTFB2 has been
reported to have substantially higher, transcription-stimulating
activity in vitro than h-mtTFB1 (21).However, studies in vivo only
support a role formtTFB2 in transcription, withmtTFB1 contrib-
uting to translation (23–26). Recently, it was shown that the ami-
no-terminal region of h-mtTFB2 interacts with the TSS, stabiliz-
ing themelted promoter and the initiating nucleotide (27).
Human mitochondrial transcription has been studied for
quite some time on plasmid-based templates by using cell-free
extracts and proteins purified from eukaryotic expression sys-
tems (21, 28, 29). All of these studies have used production of
run-off transcription products to report on events occurring dur-
ing transcription initiation, andmost of these studies have focused
ononeor twopromoters in isolation.Very little isknownabout the
structure-function relationships of the protein components of
humanmitochondrial transcription (27, 29, 30), likely a reflection
of the low yields and intense labor associated with production of
recombinant proteins in eukaryotic systems.
Here we show that post-translational modifications of the
human mitochondrial transcription machinery are not
required for specific and efficient transcription initiation in
vitro as the proteins produced in Escherichia coli appear to be
completely active. LSP- and HSP1-based DNA oligonucleotide
templates can be used to monitor transcription initiation
and/or transcription elongation. Using this system,we show for
the first time that the transcription factors and polymerase are
required in a 1:1:1 stoichiometry relative to template for assem-
bly of a functional transcription complex. Formation of the first
dinucleotide is limited by open complex formation and requires
high concentrations of ATP. Open complex formation requires
both transcription factors A and B2, although only B2 is
required after open complex formation. Interestingly, both fac-
tor requirements and related events early in the transcription
cycle are promoter-dependent, consistent with differential regu-
lation of the various promoters as suggested by others (18, 21,
31, 32). This study therefore provides the most detailed
description of the human mitochondrial transcription to
date and establishes a solid foundation for future studies of
the structure, function, mechanism, and regulation of
human mitochondrial transcription.
EXPERIMENTAL PROCEDURES
Materials—DNA oligonucleotides were from Integrated
DNA Technologies (Table 1). RNA oligonucleotides were
obtained from Dharmacon. Plasmids containing the human
mtDNApromoters pUC18-LSP, pUC18-HSP1, and pUC18-LSP-
HSP1 were a kind gift from Claes M. Gustaffson (21). Restriction
endonucleases were from New England Biolabs. T4 polynucle-
otide kinase was from United States Biochemical Corp. RQ1
DNasewas fromPromega.UltrapureNTPsolutionswere fromGE
Healthcare. [-32P]UTP (3000 Ci/mmol) and [-32P]ATP (3000
Ci/mmol) were from PerkinElmer Life Sciences. [-32P]ATP
(7000 Ci/mmol) was from MP Biomedical. HPLC-purified
[-32P]ATP (6000 Ci/mmol) was from MP Biomedical. KMnO4,
tRNA, and piperidine were from Sigma. A 10-bpDNA ladder was
from Invitrogen. Heparin (average molecular weight of 6000 Da)
was fromSigma.All other reagentswereof thehighest grade avail-
able from Sigma, Fisher, or VWR Scientific.
Recombinant Human Mitochondrial Transcription Pro-
teins—The proteins used to perform this study can be obtained
from Enzymax, LLC (Lexington, KY). Expression and purifica-
tion of h-mtRNAP (amino acids 42–1230 of accession number
NM_005035.2) will be published elsewhere. Expression and
purification of h-mtTFA (amino acids 42–246 of accession
numberNM_003201.1) have been reported (30, 33). Expression
and purification of h-mtTFB2 (amino acids 31–396 of acces-
sion number NM_022366.1) followed a strategy similar to that
for h-mtRNAP, the details of which will be published else-
where. A related strategy was also recently reported (27).
Purification of DNA Oligonucleotides—DNA oligonucleo-
tideswere purified by denaturing PAGE as described previously
(34). Briefly, oligonucleotides were resolved by denaturing
PAGE on 6% gels (37:3, acrylamide:bisacrylamide ratio). The
oligonucleotide ladder was visualized by UV shadowing; a gel
slice containing only the full-length oligonucleotide was
removed, and the nucleic acid was electroeluted from the gel in
1 TBE (89 mM Tris base, 89 mM boric acid, and 2 mM EDTA)
by using an Elutrap apparatus (Schleicher & Schuell). Oligonu-
cleotides were desalted on Sep-Pak columns (Millipore) as
TABLE 1
Oligonucleotides used in this study
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specified by the manufacturer and suspended in 10 mM Tris-
HCl, 0.1 mM EDTA. Concentrations were determined by mea-
suring the absorbance at 260 nmusing aNanodrop spectropho-
tometer and the appropriate calculated extinction coefficient.
5-32P Labeling of DNA and RNA Oligonucleotides—DNA
oligonucleotides were end-labeled by using [-32P]ATP (7000
Ci/mmol) andT4 polynucleotide kinase. Reactions, typically 50
l, contained 1 T4 polynucleotide kinase buffer provided by
the manufacturer, 1 M [-32P]ATP, 50 M DNA oligonucleo-
tide, and 0.4 unit/l T4 polynucleotide kinase. Reactions were
incubated at 37 °C for 60 min and then placed at 65 °C for 10
min to heat-inactivate T4 polynucleotide kinase. The dinucle-
otide RNA pApA was end-labeled by using HPLC-purified
[-32P]ATP (6000 Ci/mmol) and T4 polynucleotide kinase by
using an exchange reaction. Reactions, typically 20 l, con-
tained 1 exchange buffer (50 mM imidazole, pH 6.4, 12 mM
MgCl2, 1 mM 2-mercaptoethanol, and 70 M ADP), 0.36 M
HPLC-purified [-32P]ATP, 10 M pApA, and 0.4 unit/l T4
polynucleotide kinase. Reactions were incubated at 37 °C for 60
min and then placed at 65 °C for 10 min to heat-inactivate T4
polynucleotide kinase. Labeling of the DNA ladder was per-
formed by using [-32P]ATP and T4 polynucleotide kinase as
specified by Invitrogen.
Annealing of DNA Oligonucleotides—For each pair of oligo-
nucleotides, the nontemplating and templating strand (top and
bottom strand) were annealed at 25 M in 10 mM Tris-HCl, pH
8.0, 0.1 mM EDTA, and 50 mM NaCl by using a Progene Ther-
mocycler (Techne). Annealing reactions were heated to 90 °C
for 1 min and slowly cooled to 10 °C at a rate of 5 °C/min.
Annealing was confirmed by native 6% PAGE.
Linearization of pUC18 Plasmids—Linearization reactions
contained 1–5 g of pUC18 plasmid DNA. Digestions were
performed as specified by New England Biolabs. After linear-
ization, reactions were placed at 65 °C for 10 min to heat-inac-
tivate the restriction endonuclease prior to use.
In Vitro Transcription Reactions Using Plasmids as Temp-
lates—Reactions contained 1 reaction buffer (10 mMHEPES,
pH 7.5, 20 mM NaCl, 10 mM MgCl2, 1 mM DTT, and 0.1 g/l
bovine serum albumin), 4 nM linearized pUC18 plasmid DNA,
1 NTP mix (400 M ATP, 150 M CTP, 150 M GTP, 10 M
UTP, 0.2 Ci/l [-32P]UTP), 100 nM h-mtTFA, 20 nM h-
mtTFB2, and 20 nM h-mtRNAP (final concentrations). Reac-
tions were performed by incubating linearized plasmid DNA in
reaction buffer at 32 °C for 5min and then adding in the follow-
ing order: h-mtTFA, h-mtTFB2, and h-mtRNAP. Between each
addition of protein to the reaction, there was an incubation
time of 1 min. After addition of h-mtRNAP, the reaction was
allowed to incubate at 32 °C for 5 min and then initiated by
addition of NTP mix. The reaction was allowed to proceed for
30 min and then quenched by addition of stop buffer (35%
formamide, 0.0125% bromphenol blue, 0.0125% xylene cyanol,
and 50 mM EDTA final). Products were resolved by denaturing
5% (37:3, acrylamide:bisacrylamide ratio) PAGE. Proteins were
diluted immediately prior to use in 10mMHEPES, pH 7.5, 1mM
DTT, and 20% glycerol. The volume of protein added to any
reaction was always less than or equal to one-tenth the total
volume. Any deviations from the above are indicated in the
appropriate figure legend.
In Vitro Transcription Using Oligonucleotides as Temp-
lates—Reactionswere performed essentially as described above
for using plasmids as templates, except for the following mod-
ifications. Reactions contained 10 mM HEPES, pH 7.5, 100 mM
NaCl, 10 mM MgCl2, 1 mM DTT, 0.1 g/l bovine serum albu-
min, 2.5MDNAoligonucleotide duplex, 500MATP, 500M
CTP, 500MGTP, 500MUTP, 0.2Ci/l [-32P]ATP, 2.5M
h-mtTFA, 2.5Mh-mtTFB2, and 2.5Mh-mtRNAP (final con-
centrations). Where indicated, reactions contained 10 M 32P-
labeled pApA dinucleotide primer and/or 10 M heparin as
trap. In reactions that contained 32P-labeled pApA, [-32P]ATP
was not included. Reactions were assembled, initiated as
described above, and quenched at various times by addition of
stop buffer (35% formamide, 0.0125% bromphenol blue,
0.0125% xylene cyanol, and 50 mM EDTA final). Products were
resolved by denaturing 28% (25:3, acrylamide:bisacrylamide
ratio) PAGE. Proteins were diluted immediately prior to use in
10 mM HEPES, pH 7.5, 1 mM DTT, and 20% glycerol. The vol-
ume of protein added to any reaction was always less than or
equal to one-tenth the total volume. Any deviations from the
above are indicated in the appropriate figure legend.
DNase I Footprinting—Reactions were assembled as de-
scribed above for in vitro transcription reactions using oligonu-
cleotides as templates but instead using 2.5 M 32P-labeled
DNA oligonucleotide duplex. The 32P-labeledDNAduplex con-
tained only one of the DNA strands labeled in a given reaction
(template or nontemplate strand). Reactions were assembled as
described above and then initiated by addition of RQ1 DNase
(0.002 units/l) and CaCl2 (1 mM). The reaction was allowed to
proceed for 2 min and then quenched by stop/trap buffer (35%
formamide, 0.0125% bromphenol blue, 0.0125% xylene cyanol, 50
mM EDTA final) and 25 M trap strand final. The trap strand is
unlabeledDNAoligonucleotide that is of the samesequenceof the
32P-labeledDNAoligonucleotide in the reaction.This is necessary
for improved resolution of theDNA fragments during PAGE (35).
Quenched reactions were heated to 90 °C for 1 min and slowly
cooled to10 °Cat a rateof 5 °C/minusingaProgeneThermocycler
prior toPAGE.Productswere resolvedbydenaturingPAGEon8%
gels (37:3, acrylamide:bisacrylamide ratio). DNase I patterns were
quantified using the line tool in ImageQuant 5.2. The data were
normalized to the intensity of the band corresponding to position
40 and plotted using Excel.
Potassium Permanganate (KMnO4) Footprinting—Reactions
were assembled as described above for DNase I footprinting, in
a buffer modified to contain only 0.1 mM DTT. Reactions were
initiated by addition of KMnO4 (30mM), allowed to proceed for
2 min at 32 °C, and then quenched by addition of KMnO4 stop/
quench buffer (100 mM -mercaptoethanol, 0.1 g/l tRNA,
and 0.3 M sodium acetate final concentrations). The quenched
reactions were ethanol-precipitated by adding 200 l of 100%
ethanol, placed on dry ice for 10 min, and centrifuged 5 min at
16,000  g. The pellet was washed with 200 l of 70% ethanol,
centrifuged again, dried, and suspended in 30 l of 1 M piperi-
dine. The piperidine cleavage reaction was performed at 90 °C
for 30min using a ProgeneThermocycler. After 30min, 50l of
100% butanol was added and centrifuged for 5 min at 16,000 
g. The organic phase was discarded, and the aqueous phase was
ethanol-precipitated as described above. The pellet was sus-
Human Mitochondrial Transcription
MAY 21, 2010 • VOLUME 285 • NUMBER 21 JOURNAL OF BIOLOGICAL CHEMISTRY 16389
pended in 90% formamide, 0.0125% bromphenol blue, and
0.0125% xylene cyanol and resolved by denaturing 8% (37:3,
acrylamide:bisacrylamide ratio) PAGE.
Product Analysis, Denaturing PAGE andQuantitation—The
quenched reaction mixtures were heated to 70 °C for 5 min
prior to loading 5 l on a denaturing polyacrylamide gel con-
taining 1 TBE (89 mM Tris base, 89 mM boric acid, 2 mM
EDTA) and 7Murea. Electrophoresis was performed in 1TBE
at 85watts. Gels were exposed to a PhosphorImager screen (GE
Healthcare) and scanned using a Typhoon 9410 (GE Health-
care). Gels were visualized by using a phosphorimager and
quantitated by using the ImageQuant software (GE Health-
care). The amount of RNA product was determined by dividing
the volume of each product by the total volume in each lane and
multiplying by the total concentration (labeled and unlabeled)
of the 32P-labeled species in the reaction. Bar graphs and time
courses were produced by using GraphPad Prism version 4
(GraphPad software). Each graph is representative of at least
two independent experiments.
RESULTS AND DISCUSSION
Human Mitochondrial Transcription Proteins Produced in
E. coli Support Promoter- and Factor-dependent Transcription
in Vitro—Our current understanding of the biochemistry of
human mitochondrial transcription derives primarily from
studies performed in cell-free extracts (10–12). Reconstitution
of human mitochondrial transcription by using purified proteins
has only been reported for proteins produced in a eukaryotic sys-
tem, the baculovirus/insect cell expression system (21), although
active human mitochondrial transcription factor A (h-mtTFA,
also known as TFAM) can be produced in bacteria (30, 33).
Eukaryotic expression systems are generally more costly and pro-
duce lessproteins thanprokaryotic systems.Our successwithpro-
ducing the human mitochondrial DNA-dependent RNA poly-
merase (h-mtRNAP, alsoknownasPOLRMT) inE. colimotivated
us to pursue production of transcription factors A, B1, and B2
(h-mtTFA, also known as TFAM; h-mtTFB1, also known as
TFB1M; h-mtTFB2, also known as TFB2M) in E. coli. All three
proteinscanbe isolated fromE. coli ina soluble form(Fig. 1a) (data
not shown) free of contaminants such as nucleases and phospha-
tases that would interfere with biochemical analysis of transcrip-
tion. Transcription was not supported by mtTFB1 (data not
shown). Additional studies will be required to verify that the pro-
tein is appropriately folded, so this factor was not studied further.
Wewere concerned that proteins produced inE. colimight lack
post-translational modifications that are critical for function,
given that the only success to date has required use of a baculovi-
rus/insect cell expression system (21). Therefore, the objective of
our initial experiments was to validate the function of proteins by
using well established templates for transcription (21, 29). Plas-
midscontaininghumanmitochondrialLSPand/orHSP1were lin-
earized by restriction enzyme digestion at unique sites (Fig. 1b).
Mitochondrial transcriptionproteinswere combinedwith the lin-
earized transcription template, and in the presence of NTPs, run-
off transcripts of the expected length were produced in all cases
(Fig. 1c).
We first used the pUC18-LSP template digested with BamHI
(418-nt product) orMfeI (160-nt product). In both cases, when
h-mtRNAP was incubated in the reaction together with h-
mtTFA and h-mtTFB2, a run-off transcript of the expected size
was observed (Fig. 1c, lanes 3 and 7), suggesting that the bacte-
rially expressed proteins are capable of recognizing the LSP
promoter and the appropriate start site therein. The primer for
mtDNA replication is produced by termination of transcripts
initiated from LSP in a region referred to as CSBII (14). The
CSBII-terminated product (120 nt) was observed independent
of the site of template linearization (Fig. 1c, lanes 3 and 7),
suggesting that the bacterially produced proteins are capable of
sensing and responding to the CSBII termination signal. Tran-
scription from LSP was dependent on the polymerase and both
transcription factors as omission of any one of these proteins pre-
vented production of detectable levels of either CSBII-terminated
or run-off transcript (Fig. 1c, compare lane 3with lanes 1, 2, and 4
and lane 7 with lanes 5, 6, and 8), suggesting that bacterially pro-
duced polymerase exhibits the appropriate factor dependence for
recognition of and initiation and elongation on LSP.
We also validated the human mitochondrial proteins pro-
duced in E. coli on HSP1. Consistent with the results obtained
for LSP, run-off transcription products of the expected size
weremade by the polymerase onHSP1 (Fig. 1c, lanes 11 and 15)
in a manner that was most efficient when both transcription
factors were present (Fig. 1c, compare lane 11 with lanes 9, 10,
and 12 and lane 15 with lanes 13, 14, and 16). In the absence of
h-mtTFA, some run-off product was reproducibly detected
(Fig. 1c, lanes 12 and 16). This observation is quite intriguing
and has been further explored as part of another study.3
To rule out the remote possibility that the observationsmade
abovewere coincidental, we utilized a plasmid lacking themito-
chondrial promoter sequences as DNA template for in vitro
transcription. This template failed to produce products similar
to those obtained using LSP or HSP1, although some RNA
products could be produced by the polymerase in a transcrip-
tion factor-dependent manner (supplemental Fig. S1).
There has been some suggestion that LSP is a stronger pro-
moter than HSP1 (18, 21). The data presented above do not
reveal a substantial difference in utilization of the two promot-
ers. Previous studies that have observed preferential utilization
of LSP have been performed in the context of dual promoter
constructs. Therefore, we utilized a transcription template that
contained LSP, HSP1, and the natural inter-promoter DNA
sequence (Fig. 1b, pUC18-LSP-HSP1) (21).When transcription
templates were produced by digesting the dual promoter con-
struct withMfeI (120- and 160-nt products fromLSP) andNdeI
(399-nt product from HSP1), the three RNA transcripts of the
predicted size were observed (Fig. 1c, lane 20), the synthesis of
which required both transcription factors (Fig. 1c, compare
lane 20 with lanes 17–19). In this context, utilization of LSP is
substantially more efficient (Fig. 1c, lane 20), suggesting that
the bacterially produced proteins recapitulate all of the phe-
nomena reported to date regarding transcription initiation
from LSP and HSP1. The basis for the enhanced efficiency of
LSP relative to HSP1 is unclear but may be important in
3 T. E. Shutt, M. F. Lodeiro, J. Cotney, C. E. Cameron, and G. S. Shadel, submitted
for publication.
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terms of the differential regulation of these promoters in vivo
(10, 21, 36).
It is important to note that conditions in which our experi-
ments were performed were nearly identical to the conditions
reported for the proteins produced using the baculovirus/in-
sect cell expression system (21). It is important to note that the
concentrations of proteins used are at least 5-fold higher than
that for plasmid DNA template. The requirement for an excess
of protein relative to promoter is likely due to the abundance of
nonspecific DNA. To a first approximation, the yield of RNA
was equivalent to that observed previously. Therefore, the
activity of our proteins is likely identical to proteins derived
from the eukaryotic system. We conclude that post-transla-
tional modifications are not required for assembly or function
of the transcription components, at least under the conditions
employed here, which essentially provide a long period of time
for assembly of the initiation complex.
Transcripts Produced under Standard Assay Conditions
Derive from Multiple Rounds of Transcription Initiation—Our
understanding of humanmitochondrial transcription initiation
derives from biochemical experiments that monitor products
of transcription elongation formed, most likely, after multiple
rounds of transcription initiation (21, 29, 30, 32, 37). Therefore,
we sought a more direct approach to interrogate initiation of
mitochondrial transcription.
We first asked whether the transcription products observed
in a standard run-off transcription experiment derive from a
single or multiple rounds of transcription initiation. To do so,
we performed the experiments described above in the presence
or absence of heparin. Heparin is a negatively charged polysac-
charide that is an efficient trap for polymerases and other
nucleic acid-binding proteins when not bound to nucleic acid.
After a single initiation cycle, a polymerase that terminates and
disengages from the template should be trapped by heparin.
Thus, heparin prevents new initiation events therefore permit-
ting the study of a single round of transcription.Wedetermined
experimentally that the concentration of heparin that com-
pletely inhibits initiation is in the 0.5 to 1.0 M range
(supplemental Fig. S2). We refer to this type of experiment as a
“pretrap” experiment as heparin is present during the assembly
of the initiation complex. The subsequent experiments
employed 1 M heparin.
FIGURE 1. Human mitochondrial transcription machinery produced in E. coli supports promoter-dependent transcription on established plasmid-
based templates in vitro. a, recombinant human mitochondrial transcription proteins used in this study. Proteins (5 g) were resolved by SDS-PAGE on a 10%
gel and visualized by Coomassie staining. b, plasmid-based templates for in vitro transcription. Schematic of pUC18-LSP, pUC18-HSP1, and pUC18-LSP-HSP1
plasmids used in this study (21). The position of unique restriction sites and the sizes (in nucleotides, nt) of the corresponding run-off transcripts are indicated.
A 120-nt transcript will be produced from LSP regardless of the restriction enzyme used because of premature termination caused by the conserved sequence
block II (CSBII). c, transcription assays. Reactions were performed by combining h-mtTFA (100 nM) and h-mtTFB2 (20 nM) with linearized plasmid DNA (4 nM) in
reaction buffer containing NTP mix (400 M ATP, 150 M CTP, 150 M GTP, 10 M UTP, and 0.2 Ci/l [-32P]UTP) at 32 °C, initiated by addition of h-mtRNAP (20
nM), and quenched after 30 min by addition of stop buffer. Products were resolved by denaturing PAGE on 5% gels and visualized by phosphorimaging. The size
of run-off transcripts produced from the different linearized plasmid templates is indicated. The size of selected bands from a 10-bp DNA ladder (M) is indicated
as a reference.
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Our experimental design is illustrated in Fig. 2a.We initiated
the transcription reaction by pulsing with ATP, which is both
the first, second, and third nucleotide utilized during initiation,
for 30 s. Next, we chased the initiated product with NTPs in the
presence or absence of heparin. LSP transcripts of the expected
size and quantity were observed in the absence (Fig. 2b, lane 1)
or presence (Fig. 2b, lane 2) of an ATP pulse as long as the four
NTP chase was performed in the absence of heparin. However,
an ATP pulse was required to form product when the four NTP
chase was performed in the presence of heparin (Fig. 2b, com-
pare lane 3with lane 4), suggesting that binding of the initiation
nucleotide(s) and/or formation of di- or trinucleotide products
was required to forman initiation complex that is resistant to hep-
arin. The amount of transcript produced when the chase con-
tained heparin (that reports on a single round of transcription) is
substantially lower than the amount produced in the chase with-
out heparin, indicating thatmost of the transcripts observed in the
experiments performed above and by others (18, 21, 28–30, 32,
36–39) derive frommultiple rounds of transcription initiation. A
similar result was obtained when the transcription reaction was
directed by HSP1 (Fig. 2b, lanes 5–8).
Formation of Heparin-resistant Transcription-Initiation
Complexes Requires the Initiating Nucleotide (ATP) and Is
Dependent on Its Concentration—The ability to form heparin-
resistant, transcription-initiation complexes provided the
opportunity to determine the requirements for formation of
this complex. Other NTPs, in particular GTP and UTP, did not
support significant accumulation of the heparin-stable com-
plex (supplemental Fig. S3b), suggesting that the initiation
nucleotide is required. Because the first three nucleotides tem-
plated are adenylate residues, it was not clear if ATP binding
was sufficient to form the heparin-stable complex. In the T7
transcription system, the first nucleotide can be replaced by the
nucleoside and its mono- and diphosphorylated derivatives
(40). Some heparin-stable complex was formed on LSP
(supplemental Fig. S3c) and HSP1 (supplemental Fig. S3d) by
using ADP and AMP as the initiating nucleotide. However, we
were unable to exclude the presence of trace ATP contaminants.
We suggest that the ability of the pulsed nucleotide to undergo
catalysis to form the di- and/or trinucleotide products enhances
resistance of the transcription initiation complex to heparin.
Next, we evaluated the ATP concentration dependence of
the reaction in the presence and absence of heparin. We rea-
soned that if the values for the concentration of ATP required
for half-maximal transcription (K0.5) were the same under both
conditions, then the rate-limiting step (initiation versus elonga-
tion) may also be the same. In the absence of heparin, a lower
concentration of ATP was required for maximal transcription
(Fig. 2c, lanes 1–6) relative to its absence (Fig. 2c, lanes 7–12).
Indeed, there was at least a 10-fold difference in the observed
FIGURE 2. Formation of an initiation complex that is resistant to heparin
is dependent on ATP concentration. a, experimental design. Reactions
were performed by combining h-mtTFA (100 nM), h-mtTFB2 (20 nM), and
h-mtRNAP (20 nM) to linearized plasmid DNA (4 nM) in reaction buffer at 32 °C
for 5 min. Some reactions were pulsed with ATP (400 M) for 30 s prior to
initiation of transcription with all four NTPs (400 M ATP, 150 M CTP, 150 M
GTP, 10 M UTP, and 0.2 Ci/l [-32P]UTP) in the absence or presence of
heparin (1 M). Reactions were quenched after a 30-min incubation. b, ATP is
required to form heparin-resistant complexes. Products from reactions on
LSP (left) or HSP1 (right) were resolved by denaturing PAGE on 5% gels and
visualized by phosphorimaging. In the absence of heparin, products were
formed independent of an ATP pulse on LSP (lanes 1 and 2) and HSP1 (lanes 5
and 6). In the presence of heparin, products were formed on LSP and HSP1
when pulsed with ATP (lanes 2 and 7) but not in the absence of the ATP pulse
(lanes 4 and 8). The size of selected bands from a 10-bp DNA ladder (M) is
indicated as a reference. c, ATP concentration dependence for transcription in
the absence and presence of heparin. The reaction was performed in the
absence (lanes 1– 6) or presence (lanes 7–12) of heparin as described in
b; however, the concentration of ATP used in the pulse was varied from 0.01
to 1 mM. d, formation of heparin-resistant (initiation) complexes requires high
concentration of ATP. The RNA product data (volume reported by Image-
Quant software) were plotted as a function of ATP concentration. Transcrip-
tion efficiency reaches a plateau at 1 mM ATP only in the absence of heparin,
suggesting that concentrations in excess of 1 mM are required for initiation.
When the data are fit to a hyperbola, K0.5(ATP) values for ATP of 0.2 and 2 mM
are obtained in the absence and presence of heparin, respectively.
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K0.5 values measured (Fig. 2d). Clearly, in the presence of hep-
arin, initiation is being measured so it is not surprising that the
K0.5 value for ATP is so high. The low K0.5 value in the absence
of heparin may suggest that elongation is being measured.
Regulation of transcription likely occurs at all stages of tran-
scription as follows: preinitiation, initiation, post-initiation,
elongation, and termination. Generally, the rate-limiting sub-
step of a step in a multistep pathway is the most likely point of
regulation. Obtaining information on these rate-limiting sub-
steps requires that, preferably, a single step is being interro-
gated. The experiments presented above suggest that all of the
studies performed to date that use a plasmid-based run-off
transcription template to study human mitochondrial tran-
scription cannot distinguish between transcriptional effects
arising from problems with initiation, elongation, or reinitia-
tion, especially if different from initiation (21, 29, 30, 32, 37).
The use of heparin limits these templates to a single round of
transcription. The high K0.5 values suggest that nucleotide
binding and/or di- or trinucleotide product formation may be
the rate-limiting step under these conditions. Having ATP as
the initiating nucleotides for LSP and HSP1 makes initiation of
these promoters sensitive to ATP concentration as suggested
for human and yeast mitochondrial transcription (41–43).
Oligonucleotide-based DNA Templates for the Study of
Human Mitochondrial Transcription in Vitro—The sensitivity
of the plasmid-based transcription systems is insufficient to
permit transcription initiation to be interrogated fully and its
rate-limiting sub-steps to be discovered. Therefore, we devel-
oped 90-bp DNA oligonucleotides representing LSP and HSP1
(Fig. 3a). Each 90-bp template contains the following: 1) 50 bp
upstream of the site of transcription initiation (also referred to
as the TSS and denoted as 1), which includes the h-mtTFA-
binding site (18); and 2) 40 bp of template.
We utilized these DNA oligonucleotides as template for in
vitro transcription as described above, with the exception that
the complex was assembled such that each component of the
transcription initiation complex (h-mtTFA, h-mtTFB2,
h-mtRNAP, and DNA) was present at 0.5 M. A 40-nt run-off
transcript could be produced fromboth the LSP andHSP1 tem-
plates (Fig. 3b, lanes 4 and 8). Production of the 40-nt product
using the LSP oligo required both transcription factors A and
B2 (Fig. 3b, compare lane 4 with lanes 1–3). Production of the
40-nt product using the HSP1 oligo required h-mtTFB2 (Fig.
3b, compare lanes 7 and 8with lanes 5 and 6), but some product
was detected in the absence of h-mtTFA (Fig. 3b, lane 7) as
observed with plasmids. The yield of the 40-nt product using
LSP appeared greater than the yield from HSP1 (Fig. 3b, com-
pare lane 4with lane 8), and part of this difference derives from
the difference in the specific activity of the two products. LSP-
derived transcripts contain 13 uridylate residues, and HSP1-
derived transcripts contain only 11 uridylate residues (Fig. 3a).
Together, these results confirm that DNA oligonucleotide-
based transcription templates support accurate initiation that
is dependent on the presence of transcription factors as
observed for plasmid-based transcription templates. We con-
clude that the minimal requirements for specific transcription
initiation are containedwithin these 90-bp fragments. The abil-
ity of the human mitochondrial transcription machinery to
assemble productively on DNA oligonucleotides is not surpris-
ing as this observation has been made for other transcription
systems, including the phage T7 (44–46), yeast mitochondrial
(47, 48), and bacterial (49) transcription systems.
Transcription on LSP and HSP1 Oligonucleotide Templates
Yields Abortive Products and Sub-stoichiometric Amounts of
Full-length RNA—All of the experiments performed thus far
used [-32P]UTP to label the RNA product. This selection was
driven by previous studies of human mitochondrial transcrip-
tion in vitro (21). As alluded to above, the first three nucleotides
templated by both promoters are ATP. Therefore, the earliest
products of transcription initiation cannot be observed using
[-32P]UTP. Indeed, labeling with UTP will only permit prod-
ucts greater than or equal to 6 or 18 nt to be observed from LSP
or HSP, respectively (Fig. 3a). To address this problem, we
modified our experimental design to perform labeling with
[-32P]ATP. Given that a high concentration of initiating
nucleotide is required for efficient transcription, the concentra-
tion of ATP employed was 500 M. We also elevated the con-
centration of the other nucleotides at this level. To increase the
signal for products produced at such a low specific activity of
[-32P]ATP, the components of the transcription initiation
complex were elevated by a factor of 5 to 2.5 M.
The transcription machinery was incubated with either LSP
or HSP1 oligos at 32 °C for 5 min. The reaction was initiated by
addition of the NTPmix containing [-32P]ATP. Reaction pro-
gress was monitored from 30 s to 5 min as described above;
RNA product accumulation was linear over the entire 5-min
time course. From the first time point, short dinucleotide
(2-mer) and trinucleotide (3-mer) RNAs were produced from
LSP and HSP1 and continued to accumulate over the entire
5-min reaction period (Fig. 3c). Later, full-lengthRNA (40-mer)
was observed (Fig. 3c). Very little RNA accumulated in the
4–39-nt range, although some tetranucleotide RNA was evident
late in the reaction (Fig. 3c). Interpretation of these data in the
context of the more established transcription systems (50–54)
leadsus to suggest that thedi- and trinucleotideRNAsare abortive
products and that the transition into late-initiation or elongation
complexmay occur with the production of a 4-nt RNA.
We quantified the amount of each product (2-, 3-, and
40-mer) produced after initiation of the reaction from LSP and
HSP1; the data for the 5-min time course are shown in Fig. 3d.
First, initiation from both promoters was similar, with initia-
tion from LSP exceeding that from HSP1 by no more than
2-fold (Fig. 3d). Production of abortive products exceeded the
production of full-length RNA by 10-fold, suggesting that the
transition into a mode competent for 40-mer production is
inefficient (Fig. 3c). These experiments were performed under
conditions inwhich the transcription initiation complex should
have been present at the 2.5 M level. Therefore, if all com-
plexes were competent for transcription initiation and elonga-
tion at the start of the reaction, then at least 2.5M40-merRNA
should have been rapidly produced, especially given that the
rate of nucleotide addition by the polymerase is on the order of
30 s1.4 Over the 5-min time course, no more than 10% of the
4 E. Smidansky and C. E. Cameron, unpublished results.
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expected 2.5 M 40-mer RNA was observed. This low value of
40-mer RNA could not be elevated by changing protein stoichi-
ometry or time of incubation prior to addition of nucleotides
(data not shown).
Assembly of HumanMitochondrial TranscriptionMachinery
on LSP and HSP1 Oligos—To begin to delimit the myriad pos-
sible explanations for sub-stoichiometric production of full-
length RNA using LSP and HSP1 oligo templates, we used
FIGURE 3. DNA oligonucleotide-based templates for the study of human mitochondrial transcription in vitro. a, double-stranded DNA oligonucleotides
used in this study. DNA oligonucleotides (90 bp) for LSP and HSP1 contained 50 bp upstream of the TSS (1) and a 40-bp templating region. The reported
h-mtTFA DNA-binding sites (h-mtTFA-BS) are highlighted (38). The top strand is the nontemplating strand (NTS); the bottom strand is the templating strand (TS).
b, utilization of the LSP and HSP1 oligo templates by the polymerase requires h-mtTFA and h-mtTFB2. Reactions were performed by combining one or more
of the following: h-mtTFA (0.5 M), h-mtTFB2 (0.5 M), and h-mtRNAP (0.5 M) with LSP or HSP1 oligo (0.5 M) in reaction buffer at 32 °C for 5 min prior to
initiating transcription by addition of NTP mix (400 M ATP, 150 M CTP, 150 M GTP, 10 M UTP, and 0.2 Ci/l [-32P]UTP). Reaction was quenched after 10
min. Products were resolved by denaturing PAGE on 15% gels and visualized by phosphorimaging. c, direct observation of early (abortive) initiation products.
Reactions were performed by combining h-mtTFA (2.5 M), h-mtTFB2 (2.5 M), and h-mtRNAP (2.5 M) with DNA oligonucleotide duplex (2.5 M) in reaction
buffer at 32 °C for 5 min prior to initiating transcription by addition of NTPs (500 M each) containing 0.2 Ci/l [-32P]ATP. Reactions were quenched at various
times by addition of stop buffer. Product analysis was as described in b; however a 23% gel was used. d, production of full-length RNA is inefficient. The yield
of 2-, 3-, and 40-mer RNA was determined on LSP and HSP1 oligos as described under “Experimental Procedures.”
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DNase I footprinting to analyze the extent of assembly of the
transcriptionmachinery on these templates. DNase I footprint-
ing has been used extensively to characterize the human mito-
chondrial transcription initiation complex on plasmid-based
templates (18, 32). The ability to assess promoter occupancy
should provide some information on the binding competence
of the transcription components, especially h-mtTFA (18, 28,
36, 38) and h-mtRNAP (32).
LSP andHSP1 oligo templateswere labeledwith 32P on the 5
end of the nontemplating strand (Fig. 4a). Seventy two percent
protection of LSPwas observedwhen the nontemplating strand
was labeled, and all three protein components were present
(Fig. 4, a, LSP, lane 6, and b, LSP). Protection of HSP1 was
reduced 5-fold relative to LSP (Fig. 4a, HSP1, lane 6, and b,
HSP1). As a control for specificity, an end-labeled oligo was
used whose sequence was a scrambled version of LSP (referred
to as random in supplemental Fig. S4). Essentially no protection
was observed on the random oligo (supplemental Fig. S4).
Additional changes in the pattern of protection were not
observed by increasing the amount of one or more of the pro-
tein components by a factor of 2 or 3 (data not shown).With the
exception of h-mtTFA on one labeled version of LSP (Fig. 4a,
LSP, lane 3), individual proteins and two-protein combina-
tions failed to produce substantial protection.
All of the observations described above are in good agree-
ment with available footprinting data obtained using plasmid-
based templates (32, 38). The protection pattern observed here
on the nontemplating strand-labeled LSP permits us to con-
clude that 1 eq of all protein components relative to template is
sufficient to protect the appropriate region of the template. In
solution, h-mtTFA is a monomer (33). However, h-mtTFA is
thought to formdimers onDNA (33). Additional studies will be
required to determine whether DNA-induced dimerization of
h-mtTFA is obviated by the presence of one or more of the
other components of the transcription machinery. It is likely
that all proteins are folded in a conformation that permits them
to interact specifically with each other and with DNA. Protec-
tion of HSP1 is 5-fold lower than observed for LSP, but only a
50% reduction in yield of full-length RNA fromHSP1 relative to
LSP was observed (Fig. 3, b and d). Unlike for LSP, HSP1 pro-
tection does not correlate directly with occupancy. The specific
binding activity observed for LSP does not prove complete
functional competence but is suggestive thereof. Therefore, it is
possible that the less-than-stoichiometric yield of full-length
product from LSP (and by inference HSP1) is related to a defect
that occurs after assembly of the protein components on the
promoter.
Use of a Dinucleotide Primer Does Not Overcome the Block to Effi-
cient Transcription on LSP and HSP1 Oligo Templates—
Our initial characterization of transcription products synthe-
sized fromLSP andHSP1 oligo templates revealed the accumu-
lation of di- and trinucleotide RNA products (Fig. 3c).Whether
or not these products were truly abortive, remained bound, or
could be extendedwas not clear. To address these questions, we
FIGURE 4. DNase I footprinting provides evidence for assembly of initia-
tion complexes on LSP and HSP1 oligo templates. DNase I footprinting
was performed using LSP and HSP1 DNA oligonucleotide templates. Proteins
were assembled on the indicated 32P-labeled DNA oligo (2.5 M) by combin-
ing one or more of the following components: h-mtTFA (2.5 M), h-mtTFB2
(2.5 M), and h-mtRNAP (2.5 M), as indicated, in reaction buffer at 32 °C. DNA
cleavage was initiated by addition of RQ1 DNase (0.002 unit/l) and CaCl2 (1
mM) and quenched after 2 min by addition of stop/trap buffer. Products were
resolved by denaturing PAGE on 8% gels and visualized by phosphorimaging.
The locations/orientations of the h-mtTFA-binding site and transcription start
site are indicated for the LSP and HSP1 promoters. A 10-bp ladder was used as
a size marker (M). a, footprinting was performed on LSP and HSP1 containing
32P in the 5 end of the templating strand. b, quantification of selected lanes of
the gels shown in a. The intensities were normalized to the 40 position of
the control (lane 2 of LSP or HSP1 in a). Initiation complex refers to lane 6 of
LSP or HSP1 in a. Asterisk refers to the location of the 32P label.
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performed a pulse-chase experiment (supplemental Fig. S5).
The transcription complex was assembled and incubated with
[-32P]ATP for 10 s, and products were chased into full-length
RNA by addition of all four NTPs (supplemental Fig. S5a). As a
control, the labeling reaction was allowed to proceed in the
absence of added nucleotide to show that synthesis of full-
length, labeled product depended on NTP addition (supple-
mental Fig. S5a). Di- and trinucleotide products did not accu-
mulate in the presence of added NTPs (pulse-chase)
(supplemental Fig. S5b). In the absence of added NTPs (pulse
quench), di- and trinucleotide accumulated, but full-length
RNA was not produced (supplemental Fig. S5b). Curiously, a
poly(rA) ladder was produced at
longer times under these condi-
tions, perhaps due to slippage syn-
thesis as described previously for T7
RNA polymerase (51, 55). In both
the T7 and bacterial transcription
systems, abortive products accumu-
late over the entire course of a reac-
tion (51, 53, 56, 57). This was not
observed for the human mitochon-
drial transcription system (see pulse-
chase in supplemental Fig. S5b),
suggesting that the transition from
initiation to elongation may be
more efficient relative to these
other transcription systems.
The apparent ability of the tran-
scription complex to efficiently and
rapidly utilize di- and trinucleotide
products provided the opportunity
to ask whether or not formation of
these products contributed to the
less-than-stoichiometric yield of
full-length RNA relative to tran-
scription template. For these exper-
iments, the transcription complex
was assembled on LSP or HSP1 in
the presence of a 32P-labeled syn-
thetic dinucleotide primer (*pApA)
(Fig. 5a). The reaction was initiated
by addition of all four NTPs in the
absence or presence of heparin,
and reaction progress was moni-
tored for 5 min (Fig. 5a). Product
formed in the presence of heparin
should be a more accurate reflec-
tion of the quantity of active initi-
ation complexes.
In the absenceofheparin, thedinu-
cleotide was converted to 3-mer,
4-mer, and full-length 40-mer RNAs
using LSP (Fig. 5b, heparin) or
HSP1 (Fig. 5c,heparin). In thepres-
ence of heparin, the same product
distribution was observed, but the
yield of RNA product was reduced
substantially (heparin in Fig. 5, b and c). Quantitation of the
products formed revealed that, in the absence of heparin, the
yield of RNA products from a dinucleotide primer on LSP and
HSP1 (Fig. 5d) was equivalent to that produced by using ATP
on these promoters (Fig. 3d). We conclude that formation of
the dinucleotide, and likely other short initiation products, does
not limit formation of full-lengthRNA.This conclusionwas not
changed by increasing the concentration of pApA in the reac-
tion (data not shown). In the presence of heparin, the yield of
RNA products was reduced by a factor of 10 (Fig. 5e). This
observationwas striking in that it suggested that only 10%of the
complexes were functioning. Therefore, it was again possible
FIGURE 5. Initiation of RNA synthesis by using a dinucleotide RNA primer does not increase transcription
efficiency relative to initiation de novo on LSP or HSP1. a, experimental design. Reactions were performed
by combining h-mtTFA (2.5 M), h-mtTFB2 (2.5 M), and h-mtRNAP (2.5 M) with DNA oligonucleotide duplex
(2.5 M) and 32P-labeled dinucleotide (*pApA) RNA (10 M) in reaction buffer at 32 °C for 5 min. The reaction
was initiated by addition of NTPs (500 M each) in the absence or presence of heparin (10 M) and then
quenched at various times by addition of stop buffer. Reaction products were resolved by denaturing PAGE on
25% gels and visualized by phosphorimaging. b, representative gel of an experiment using LSP as template.
c, representative gel of an experiment using HSP1 as template. d, comparison of the average amount of the
indicated RNA product formed at 120 s on LSP and HSP1 in the absence of heparin. e, comparison of the
average amount of the indicated RNA product formed at 120 s on LSP or HSP1 in the presence of heparin.
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that under conditions in which multiple turnovers were
allowed, only a very small fraction of the input proteins was
functioning.
When a labeled dinucleotide was employed, products origi-
nating from initiation de novo would be missed. To rule out a
preference for initiation de novo and to further define differ-
ences between dinucleotide-primed and de novo RNA synthe-
sis, an experiment was performed in which [-32P]UTP was
again used for labeling in the presence or absence of the dinu-
cleotide primer and under conditions in which the ATP con-
centration was varied (Fig. 6). This experiment showed that
the dinucleotide primer stimulated synthesis of full-length
RNA from both LSP (Fig. 6a) and HSP1 (Fig. 6b) at all con-
centrations of ATP employed. Quantitative evaluation of the
ATP concentration dependence of 40-mer synthesis by de
novo initiation yielded a K0.5 value in the 400–500 M range
for both promoters (Fig. 6, c and d). In contrast, the K0.5
value was at least 5-fold lower (70–90 M) when the dinu-
cleotide primer was used (Fig. 6, c
and d). Such a high K0.5 value for
the initiating nucleotide(s) is con-
sistent with observations made in
other transcription systems, in-
cluding the yeast mitochondrial
transcription system (43, 46, 58,
59). The efficiency of human tran-
scription should therefore be
responsive to the cellular levels of
ATP as observed for the human
and the yeast mitochondrial tran-
scription systems (41, 43).
Formation of an Open Complex Is
a Rate-limiting Step for Initiation of
Transcription on LSP and HSP1
Oligo Templates—At this point of
the study, it was still not clear if our
protein preparations were only 10%
active or if there were rate-limiting
events after assembly of the tran-
scription complex but prior to syn-
thesis of the dinucleotide product. It
is well established that formation of
an open complex, i.e.melting of the
double-stranded DNA surrounding
the transcription start site, can be a
rate-limiting step for transcription
initiation (42, 59–62). To deter-
mine whether an open complex was
forming on LSP and HSP1 oligos
after assembly of the transcription
machinery, we used KMnO4 reac-
tivity (63, 64). KMnO4 will readily
oxidize thymine bases of single-
stranded DNA and sensitize the
phosphodiester backbone to pi-
peridine cleavage at the sites of
modification (64). This approach
is well suited to the study of the
LSP and HSP1 promoters given the number of thymidines
surrounding the transcription start site (Fig. 3a). When this
experiment was performed, we were unable to detect any
KMnO4 reactivity on LSP (supplemental Fig. S6a) or HSP1
(supplemental Fig. S6b) in the absence or presence of any
combination of factors.
The inability to quantitatively form an open complex
would explain the low yield of RNA from the LSP and HSP1
oligo templates. To bypass the need for open complex for-
mation, we created “bubble” templates in which the region
from 1 to 3 of the template was artificially melted due to
the presence of noncomplementary nucleotides at these
positions of the nontemplating strand. The presence of the
bubble was confirmed by KMnO4 footprinting for the LSP
(supplemental Fig. S6a) and HSP1 (supplemental Fig. S6b)
bubble templates. Importantly, the presence of the tran-
scription machinery had no significant impact on the reac-
tivity of the bubble templates with KMnO4, consistent with
FIGURE 6. RNA synthesis initiated using a dinucleotide RNA primer requires lower concentrations of ATP
for maximal transcriptional efficiency than RNA synthesis initiated de novo on LSP or HSP1. Reactions
were performed by combining h-mtTFA (0.5 M), h-mtTFB2 (0.5 M), and h-mtRNAP (0.5 M) with LSP or HSP1
oligo templates (0.5 M) in the absence (pApA) or presence (pApA) of dinucleotide primer (10 M) in
reaction buffer at 32 °C for 5 min. Transcription was initiated by adding NTPs (150 M GTP, 150 M CTP, 50 M
UTP, and 0.2 Ci/l [-32P]UTP) with the concentration of ATP ranging from 50 to 1000 M. Reactions were
quenched after 2 min by addition of stop buffer. Products were resolved by denaturing PAGE on 25% gels and
visualized by phosphorimaging. a, representative gel of an experiment using LSP as template. b, representative
gel of an experiment using HSP1 as template. c, RNA product data obtained on LSP in absence (pApA, f) or
presence (pApA, F) of dinucleotide primer were expressed as a fraction of that observed at 1 mM ATP and
plotted as a function of ATP concentration. The data were fit to a hyperbola, yielding K0.5(ATP) values for ATP of
500  90 M and 70  10 M in the absence or presence of dinucleotide, respectively. d, RNA product data
obtained on HSP1 in absence (pApA, f) or presence (pApA, F) of dinucleotide primer were expressed as a
fraction of that observed at 1 mM ATP and plotted as a function of ATP concentration. The data were fit to a
hyperbola, yielding K0.5(ATP) values for ATP of 400  60 and 60  10 M in the absence or presence of dinucle-
otide, respectively.
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the absence of an open complex on the “normal” templates
(supplemental Fig. S6).
Experiments using the bubble templates were designed as
follows. A pretrap experiment, in which heparin was present at
the time of transcription complex assembly, was performed to
show that the concentration of heparin used was sufficient to
prevent reinitiation events from occurring. Experiments were
then performed inwhich the transcription complexwas assem-
bled on the bubble template in the presence of end-labeled
dinucleotide, and the reaction was initiated by addition of all
four NTPs in the presence or absence of heparin. In the pres-
ence of heparin, the concentration of active complexes should
be revealed. In the absence of heparin, the ability of these com-
plexes to recycle would be revealed.
Heparin at a concentration of 10Mwas sufficient to prevent
transcription on LSP (Fig. 7a, pretrap) and HSP1 (Fig. 7b, pre-
trap) bubble templates. When heparin was added along with
the NTPs after complex assembly, a burst of product formation
was observed on both promoters as fast as we couldmeasure by
manual quenching (heparin in Fig. 7, a and b). On LSP, the
primary products were 3–6 and 40 nts (Fig. 7a, heparin). On
HSP1, the primary products were 3–9 and 40 nts (Fig. 7b,
heparin). The amount of product formed in the presence of
heparin did not change substantially over time on either pro-
moter, with the final yield of extended dinucleotide being 5 M
on LSP and 3MonHSP1 (Fig. 7c). The product yield is now on
the order of the value expected based on the concentration of
assembled complex. Indeed, for LSP, this value exceeds that
of the complex by a factor of 2, likely because multiple rounds of
abortive synthesis are possible prior to complex dissociation.
The yield from HSP1 is lower than that from LSP, suggesting
that this complex is less stable as reported by others (21). The
differences in stability of the two transcription complexes may
reflect differences in organization of the complex imposed by
differences in the positions of the TFA-binding sites relative to
the transcription start site (Fig. 3a). We now conclude that the
transcription machinery is fully active and that formation of an
open complex is a major obstacle to transcription on linear,
double-stranded oligo templates and likely linear, plasmid-
based templates as well. We speculate that the use of a relaxed,
circular template more like mtDNAmay permit strain induced
by the binding and/or bending of h-mtTFA to be harnessed for
promoter melting.
The reason for the promoter-dependent differences in the
observed lengths of the intermediate products (heparin in
Fig. 7,a and b) is not clear andhas not been observed previously.
This observation may suggest that differences exist in the reg-
ulation of LSP relative toHSP1 after open complex formation in
vitro. The “stuttering” observed on HSP1 occurs in a GC-rich
stretch of the templating strand (Fig. 3a). The high GC content
of CSBII is thought to contribute to the termination activity of
that sequence (14).
In the absence of heparin, all of the dinucleotide primer is
consumed andmore full-length RNA is produced (heparin in
Fig. 7, a and b), suggesting that the complexes can recycle.
Dinucleotide primer is consumed faster on LSP than on HSP
(compare Fig. 7, a, heparin, with b, heparin). This differ-
ence in primer consumption again suggests differences in reg-
ulation of LSP relative to HSP. Reiterative synthesis of abortive
products 3–4 nt in lengthmay occur on LSPwithout the neces-
sity for polymerase to escape the promoter and may be driven
by dissociation of the abortive products from the polymerase
active site. In contrast, reiterative synthesis on HSPmay be less
facile because the products 3–9 nt in length may be retained
longer in the polymerase active site, akin to pausing observed by
multisubunit RNA polymerases (65–68). Although additional
studies will be required to sort out the mechanistic basis for
these differences, these studies provide the first indication that
the early events of transcription initiation on LSP differ sub-
stantially from those on HSP1. Full-length product produced
on HSP1 is on par with that produced on LSP (see 40-mer on
Fig. 7d), despite the differences in complex assembly, stability,
and initiation efficiency discussed above. Perhaps the reduced
complex stability on HSP1 leads to a greater efficiency of pro-
moter clearance. In neither case does the amount of full-length
product approach a level stoichiometric with the template (see
40-mer in Fig. 7d). This observationmay suggest that promoter
clearance and transition into a fully elongation competent tran-
scription complex may represent another rate-limiting step
during the human mitochondrial transcription cycle. The rea-
son that abortive products are not used (Fig. 7a), as predicted by
the pulse-chase experiments (supplemental Fig. S5), is not
known but could reflect a difference in the size of the open
complex on the bubble templates relative to the size of the open
complex on double-stranded templates and/or loss of
sequence-specific interactions with the nontemplating strand
caused by creation of the artificial bubble. Additional studies
will be required to resolve this issue.
One final control was performed to show that the observa-
tions discussed above were specified by the promoter sequence
and not just the presence of a bubble. When a bubble template
was constructed by using the LSP-scrambled (random)
sequence, products were not formed by the polymerase in the
absence or presence of transcription factors when RNA synthe-
sis was initiated by using a dinucleotide primer (supplemental
Fig. S7a) or de novo (supplemental Fig. S7b).
Use of Bubble Templates Relaxes Transcription Factor
Dependence, Further Distinguishes LSP fromHSP1, and Reveals
the Existence of a Post-initiation Step That Limits the Efficiency
of Full-length RNA Synthesis—The ability of a bubble template
to bypass the primary, rate-limiting step for transcription initi-
ation in vitro on linear templates provided the opportunity to
study the contributions of the different transcription factors
before and after open complex formation. Experiments were
performed on the LSP bubble template (Fig. 8a) and the HSP1
bubble template (Fig. 8b) in the presence of heparin. Produc-
tion of full-length RNA was no longer as dependent on the
presence of h-mtTFA as observed on the templates lacking a
bubble (Fig. 3b), suggesting that h-mtTFA functions primarily
at steps that lead to formation of the open complex. In most
cases, h-mtTFB2was required, suggesting that h-mtTFB2 func-
tions before and after open complex formation, consistent with
a recent report from Temiakov and co-workers (27). However,
bubble templates did not require any transcription factors in
that study (27). This difference may reflect the larger bubble
and/or much longer reaction times employed (27). In all cases,
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the presence of all three protein components led to an increase
in the amount of overall transcription (Fig. 8c, heparin) likely
because the combination of all three protein components is
more stable on the promoter, consistent with DNase I foot-
printing experiments (Fig. 4a) and, consequently, also more
resistant to heparin.
Experiments performed on the bubble templates in the
absence of heparin reveal a substantial difference in the intrin-
sic properties of the two promoters. On LSP, polymerase in
combination with either h-mtTFA or h-mtTFB2 is sufficient to
initiate (Fig. 8a, heparin) and produce amounts of full-length
RNA equivalent to that produced in the presence of both fac-
tors (Fig. 8c, heparin). In contrast, on HSP1, polymerase and
h-mtTFA were essentially inactive (Fig. 8b, heparin). It has
been shown recently for the yeast mitochondrial RNA poly-
merase that a region of the polymerase termed the specificity
loop interactswith the promoter (47). The same is likely true for
the human mitochondrial polymerase. The need for an addi-
tional factor on the LSP bubble template may suggest that the
polymerase alone is not retained at the transcription start site
FIGURE 7. Open complex formation is a rate-limiting step for transcription initiation on LSP and HSP1 revealed by using bubble templates. Reactions
were performed by combining h-mtTFA (2.5 M), h-mtTFB2 (2.5 M), and h-mtRNAP (2.5 M) with LSP or HSP1 bubble templates (2.5 M) and 32P-labeled
dinucleotide (*pApA, 10 M) in reaction buffer at 32 °C for 5 min. The reaction was initiated by addition of NTPs (500 M each) in the presence or absence of
heparin (10 M) and then quenched at various times by addition of stop buffer. For the pretrap experiment, heparin (10 M) was included during the assembly
of proteins on DNA. a, representative gel of an experiment using LSP bubble template. b, representative gel of an experiment using HSP1 bubble template.
c, comparison of the average amount of the indicated RNA product formed at 120 s on LSP and HSP1 bubble templates in the presence of heparin. d, com-
parison of the average amount of the indicated RNA product formed at 120 s on LSP and HSP1 in the absence of heparin.
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long enough to do catalysis. Consistent with this possibility is
the observation that either h-mtTFA or h-mtTFB2 function
equivalently on the LSP bubble template. Clearly, the roles for
these two factors in transcription are mechanistically distinct.
As discussed earlier, h-mtTFA is thought to bind and bend
DNA to facilitate open complex formation (11, 12, 30, 33).
However, h-mtTFB2 is thought to interact with the templating
strand in the vicinity of the transcription start site, as well as the
initiating nucleotide(s) (27). This assay will prove useful in
determining the physical basis for functional interaction of
h-mtTFA with h-mtRNAP and h-mtTFB2 with h-mtRNAP.
The reason that only h-mtTFB2 is sufficient to activate use of
the HSP1 bubble template is not at
all clear, but this observation further
highlights the likelihood that LSP
and HSP1 are regulated differently.
Finally, there is a lack of corre-
spondence between the efficiency of
initiation (the amount of 3- and 4-nt
product) and the amount of full-
length RNA produced. The lack of
correspondence on LSP is shown
best by the experiment performed
in the absence of heparin (Fig. 8a),
where the dinucleotide primer is
completely converted to 3- and
4-mer by the polymerase in the
presence of both transcription fac-
tors and is only partially converted
in the presence of h-mtTFA or
h-mtTFB2, but the amount of
40-mer produced is essentially the
same in all cases. The lack of corre-
spondence on HSP1 is shown best
by the experiment performed in the
presence of heparin, where the same
amount of 3- and 4-mer is produced
by the polymerase in the presence of
both transcription factors and in the
presence of only h-mtTFB2, but the
amount of 40-mer produced is dif-
ferent in these two situations.
Together, these observations lead
us to propose that a step after initi-
ation exists that leads to formation
of a competent elongation complex.
Moreover, we suggest that the tran-
sit efficiency through this step, and
perhaps regulation of this step, dif-
fers between the two promoters,
consistent with observations made
by considering the differences in the
nature of the intermediate RNA
products observed between the two
promoters (Fig. 7, a and b).
Conclusions—We have reconsti-
tuted human mitochondrial tran-
scription in vitro using protein com-
ponents produced in E. coli, permitting us to conclude that
post-translational modifications are not required for efficient
and specific initiation in vitro. The utility of these proteins has
been validated by using conventional, plasmid-based assay sys-
tems developed by others to study human mitochondrial tran-
scription in cell-free extracts and with proteins produced using
a baculovirus/insect cell expression system (Figs. 1 and 2 and
supplemental Figs. S1–S3) (21). To date, all studies of human
mitochondrial transcription have employed full-length elonga-
tion products as a surrogate for transactions that lead to assem-
bly and function of the transcription initiation complex, regard-
less of the nature of the templates used (21, 27, 29, 32).We have
FIGURE 8. Unique factor dependence of LSP relative to HSP1 when bubble templates are used. Proteins
were assembled on the LSP1 or HSP1 bubble template (2.5 M) by combining one or more of the following
components: h-mtTFA (2.5 M), h-mtTFB2 (2.5 M), and h-mtRNAP (2.5 M), as indicated, and 32P-labeled
dinucleotide primer (*pApA, 10 M) in reaction buffer at 32 °C for 5 min. The reaction was initiated by addition
of NTPs (500 M each) in the presence or absence of heparin (10 M) and then quenched at various times by
addition of stop buffer. Products were resolved by denaturing PAGE on 25% gels and visualized by phos-
phorimaging. a, representative gel of an experiment using LSP bubble template. b, representative gel of an
experiment using HSP1 bubble template.
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succeeded in assembling transcription initiation complexes on
DNA oligonucleotide templates representing LSP and HSP1 at
concentrations that permit, for the first time, direct analysis of
both transcription initiation and transcription elongation (Figs.
3–8 and supplemental Figs. S5–S7). The major findings of this
study have been integrated into the context of a model for the
human mitochondrial transcription cycle shown in Fig. 9.
The polymerase and transcription factors A and B2 assemble
on the LSP or HSP1 promoter. The order of assembly, if any,
was not addressed by this study. However, we were able to
determine the stoichiometry of the transcription complex for
the first time. We observed that 1 eq of each protein relative to
DNA is sufficient to assemble themaximal level of transcription
complex on the promoter (Fig. 4 and data not shown), as well as
to produce the maximal amount of RNA (Fig. 3 and data not
shown). The initiation complex is more stable on LSP than
HSP1 (Fig. 4), consistent with previous studies (21, 38). The
organization and interactions between the factors are not
known, although it is clear that h-mtRNAP interacts function-
ally with both h-mtTFA and h-mtTFB2 (Fig. 8) (21, 32) and that
h-mtTFA interacts physically with h-mtTFB2 (29). The unique
amino-terminal domain of the polymerase is shown as a bridge
of the core polymerase domain to the factors because this
domain appears to be present in all T7-like RNA polymerases
that employ transcription factors (11, 12, 29, 69). Once the ini-
tiation complex forms on linear templates, only 10% of these
complexes are competent for initiation (Fig. 5). Our data sug-
gest that formation of an open complex is a rate-limiting step
for transcription on linear templates as the use of bubble tem-
plates bypasses this step (Fig. 7). The requirement for h-
mtTFB2 is not alleviated on bubble templates, consistent with
this factor being required before and after open complex for-
mation. In contrast, the requirement for h-mtTFA is bypassed
on bubble templates (Fig. 8), suggesting that this factor contrib-
utes to open complex formation. It is possible that the inability
of h-mtTFA to shift the equilibrium from closed to open com-
plex reflects the linear nature of the template. Mitochondrial
DNA is circular, and bending of even a relaxed circular DNA
will lead tomore local unwinding of the DNAdouble helix than
bending of a linear DNA. Initiation of RNA synthesis de novo
from the open complex requires high concentrations of ATP,
given aK0.5 value on the order of 1mM (Fig. 6). Di- and trinucle-
otides are the major products when linear templates are used
(Fig. 3c), and these products chase into full-length RNA
(supplemental Fig. S5). These products are likely abortive prod-
ucts based on a yield that is greater than the polymerase con-
centration, even under conditions in which dissociated enzyme
would be inhibited (Fig. 7). Utilization of the dinucleotide prod-
uct diminished K0.5 value for ATP by at least 5-fold (Fig. 6),
consistent with observations in other transcription systems
that the Km value for elongating nucleotides is lower than that
for initiating nucleotides (43, 46, 58, 59, 70). Production and
utilization of abortive products are different on the artificial,
3-bp open complex relative to that on the double-stranded tem-
plates. The basis for this difference is unknown and requires
further investigation. Finally, once efficient initiation is possi-
ble, a second rate-limiting step comes into view, namely pro-
duction of a competent elongation complex (Fig. 8). Transition
into an elongation complex appears to be promoter-dependent
(Fig. 8), giving rise to accumulation of intermediate RNAs of
different lengths (Figs. 7 and 8).
Rate-limiting steps of biochemical pathways are often those
that are targeted for regulation. Like the more complex tran-
scription systems of the eukaryotic nucleus (65, 71, 72), pro-
karyotes, and their phage (57, 70, 73–77), multiple steps may
exist for the control of human mitochondrial transcription,
including assembly of the initiation complex, formation, and/or
stabilization of the open complex, initiation of the first prod-
ucts of RNA synthesis, and transition into an elongation com-
plex. The system described herein sets the stage for detailed
studies not only of the regulation of humanmitochondrial tran-
scription in vitro but also of the structure, function, and mech-
anism of the complexes that catalyze the various stages of
human mitochondrial transcription.
FIGURE 9. Hypothetical model for the human mitochondrial transcription
cycle. The images used of the proteins and DNA should be considered sche-
matics but have been drawn to scale. Interactions of h-mtTFA with h-mtTFB2
and h-mtTFB2 with h-mtRNAP occur through carboxyl- or amino-terminal
tails of h-mtTFA or h-mtTFB2, respectively, and are not shown explicitly (27,
29). The data presented in this study are consistent with the following model.
Transcription factors and polymerase assemble on DNA to form an initiation
complex by some unknown mechanism. Once formed, the initiation complex
is quite stable. Open complexes do not accumulate based on potassium per-
manganate reactivity, creating a significant barrier to transcription initiation
that can be bypassed by using bubble templates. Formation of the first phos-
phodiester bond requires high concentrations of ATP; therefore, the effi-
ciency of this step will be controlled by the availability of ATP. Once a dinu-
cleotide is formed, the dependence of the reaction on the concentration of
ATP is reduced by a factor of 10. The transition into an elongation complex
occurs at some point after formation of the trinucleotide, occurs inefficiently,
and occurs differently on the two promoters.
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Figure S1.  Specificity of human mitochondrial transcription machinery produced in E. coli. 
Transcription reactions were performed on pUC18-LSP (lanes 1 and 2) or pUC18 (lanes 3 and 4) 
in the absence (lanes 1 and 3) or presence of h-mtTFA and h-mtTFB2 (lanes 2 and 4).  Production 
of RNA that is 100- to 300-nt in size requires both LSP and transcription factors as none of these 
products are observed by using pUC18 as a template.  Reactions were performed by combining h-
mtTFA (100 nM) and h-mtTFB2 (20 nM) to linearized plasmid DNA (4 nM) in reaction buffer 
containing NTP mix (400 µM ATP, 150 µM CTP, 150 µM GTP, 10 µM UTP, 0.2 µCi/µL [α-
32P]UTP) at 32 oC, initiated by addition of h-mtRNAP (20 nM) and quenched after 30 min by 
addition of stop buffer.  Products were resolved by denaturing PAGE on a 5% gel and visualized 
by phosphorimaging.  The size of selected bands from a 10-bp DNA ladder (M) is indicated as a 
reference. 
Figure S2.  Heparin inhibits mitochondrial transcription initiation in vitro.  (a) Experimental 
design.  Reactions were performed by combining h-mtTFA (100 nM), h-mtTFB2 (20 nM) and h-
mtRNAP (20 nM) with linearized pUC18-LSP-HSP1 (4 nM) in reaction buffer at 32 oC for 5 
min, transcription was initiated by addition of NTP mix (400 µM ATP, 150 µM CTP, 150 µM 
GTP, 10 µM UTP, 0.2 µCi/µL [α-32P]UTP) in the absence or presence of increasing 
concentrations of heparin (0.005- 5 µM). The reactions were quenched after 30 min by addition 
of stop buffer.  Products were resolved by denaturing PAGE on a 5% gel and visualized by 
phosphorimaging.  The size of selected bands from a 10-bp DNA ladder (M) is indicated as a 
reference.  (b) Representative gel showing that transcription on both LSP and HSP1 is inhibited 
by heparin. 
Figure S3.  Requirements for production of heparin-resistant, transcription-initiation 
complexes.  (a) Experimental design. Reactions were performed by combining h-mtTFA (100 
nM), h-mtTFB2 (20 nM) and h-mtRNAP (20 nM) with the indicated linearized plasmid DNA (4 
nM) in reaction buffer at 32 oC for 5 min.  Reactions were pulsed with the indicated nucleotide 
(400 µM) for 30 sec prior to initiating transcription elongation with all four NTPs (400 µM ATP, 
150 µM CTP, 150 µM GTP, 10 µM UTP, 0.2 µCi/µL [α-32P]-UTP) in the absence or presence of 
heparin (1 µM).  Reactions were quenched after a 30-min incubation.  Products were resolved by 
denaturing PAGE on a 5% gel and visualized by phosphorimaging.  The size of selected bands 
from a 10-bp DNA ladder (M) is indicated as a reference.  (b)  Neither GTP nor UTP (incorrect 
nucleotides) support formation of heparin-resistant complexes on LSP.  (c)  The yield of heparin-
resistant complexes on LSP is reduced by using ADP or AMP instead of ATP.  (d)  The yield of 
heparin-resistant complexes on HSP1 is reduced by using ADP or AMP instead of ATP. 
Figure S4. DNase I footprinting supports specificity of transcription complex assembly on 
DNA oligonucleotides. DNase I footprinting was performed using randomized LSP1 (random) 
ds DNA oligonucleotide templates.  Proteins were assembled on the indicated 32P-labeled DNA 
oligo (2.5 µM) by combining one or more of the following components: h-mtTFA (2.5 µM), h-
mtTFB2 (2.5 µM) and h-mtRNAP (2.5 µM), as indicated, in reaction buffer at 32 oC.  DNA 
cleavage was initiated by addition of RQ1 DNase (0.002 units/µL) and CaCl2 (1 mM) and 
quenched after 2 min by addition of stop/trap buffer.  Products were resolved by denaturing 
PAGE on 8% gels and visualized by phosphorimaging. (a) DNAse I footprint was determined by 
PAGE. A 10-bp ladder was used as a size marker (M). (b). Quantification of selected lanes was 
performed as described under Experimental Procedures.  The data were normalized to the -40 
position.  The control is from lane 2 and the initiation complex is from lane 6. 
Figure S5.  Di- and trinucleotides formed during initiation can be chased quantitatively into 
full-length RNA.  (a) Experimental design.  Reactions were performed by combining h-mtTFA 
(2.5 µM), h-mtTFB2 (2.5 µM) and h-mtRNAP (2.5 µM) with LSP or HSP1 DNA oligonucleotide 
template (2.5 µM) in reaction buffer at 32 oC for 5 min.  The assembled complex was pulsed with 
[α-32P]ATP (100 µM, 0.2 µCi/µL) for 10 seconds, then either buffer (pulse quench) or all four 
NTPs (500 µM each) (pulse chase) were added.  Reactions were quenched at the indicated times. 
Products were resolved by denaturing PAGE on a 25% gel and visualized by phosphorimaging. 
The size of selected bands from a 10-bp DNA ladder (M) is indicated as a reference.  (b) 
Representative gel.  Under pulse-quench conditions (absence of cold NTPs) on LSP and HSP, di-, 
tri- and tetranucleotides are visible from the beginning of the experiment and continue to 
accumulate.  At later time points, an A-ladder begins to appear.  In no case is 40-nt RNA 
observed.  In the chase, di-, tri- and tetranucleotide RNAs produced in the pulse are chased into 
full-length RNA as labeled di-, tri- and tetranucleotide do not accumulate. 
Figure S6.  Open complexes can only be detected on bubble templates by using KMnO4 
reactivity. KMnO4 reactivity was evaluated using LSP, HSP1 or randomized LSP (random) 
double-stranded (ds) or bubble DNA oligonucleotide templates.  Proteins were assembled on the 
indicated 32P-labeled DNA oligo (2.5 µM) by combining one or more of the following 
components: h-mtTFA (2.5 µM), h-mtTFB2 (2.5 µM) and h-mtRNAP (2.5 µM), as indicated, in 
reaction buffer at 32 oC for 5 min.  DNA modification was initiated by addition KMnO4 (30 mM) 
and allowed to proceed at 32 oC for 2 min.  (a) Representative gel for experiments performed on 
LSP or LSP-bubble templates.  (b) Representative gel for experiments performed on HSP1 or 
HSP1-bubble templates.  KMnO4 reactivity was not observed on double-stranded templates under 
any combination of polymerase and factors, suggesting that the equilibrium does not lie in the 
direction of open complex.  KMnO4 reactivity was observed on bubble templates, and the 
reactivity was not attenuated by the presence of proteins, thus ruling out another trivial 
explanation for the absence of KMnO4 reactivity with the ds templates. 
Figure S7.  Bubble templates require a promoter and transcription factors.  Reactions were 
performed by combining h-mtRNAP (2.5 µM) in the absence or presence of h-mtTFA (2.5 µM) 
and h-mtTFB2 (2.5 µM) with LSP or random (scrambled version of LSP) bubble templates (2.5 
µM) in reaction buffer at 32 oC for 5 min.  The reaction was initiated by addition of NTPs (500 
µM each).  When 32P-labeled dinucleotide (*pApA) was used, it was added with the proteins at a 
concentration of 10 µM (final).  When α-32P-ATP was used, it was added with the NTPs at the 
start of the reaction at a concentration of 0.2 µCi/µL (final). Reaction products were resolved by 
denaturing PAGE on a 25% gel and visualized by phosphorimaging. (a) Dinucleotide-primed 
RNA synthesis on LSP and random bubble templates.  Transcription is not observed on random 
template in the absence or presence of factors.  (b) De novo RNA synthesis on LSP and random 
bubble templates.  Transcription is not observed on random template in the absence or presence 
of factors. 
